Skip to main content

Table 3 Independent predictor analysis of SCC and AC

From: The value of HPV genotypes combined with clinical indicators in the classification of cervical squamous cell carcinoma and adenocarcinoma

Variable

B

S.E

Wald

P

OR

95% CI for OR

Parity

0.085

0.201

0.179

0.672

1.089

0.734–1.615

Menopausal Status

-0.426

0.369

1.327

0.249

0.653

0.317–1.348

Clinical Symptoms

  

2.804

0.246

  

 Contact Bleeding

-0.413

0.396

1.087

0.297

0.661

0.304–1.439

 Irregular Vaginal Bleeding

-0.804

0.485

2.747

0.097

0.448

0.173–1.158

SCCAg

-0.399

0.153

6.814

0.009*

0.671

0.497–0.905

CA125

-0.001

0.005

0.031

0.861

0.999

0.989–1.010

CA19-9

0.030

0.016

3.539

0.060

1.030

0.999–1.063

CYFRA 21–1

-0.174

0.142

1.496

0.221

0.841

0.636–1.110

CEA

0.003

0.010

0.089

0.765

1.003

0.983–1.024

HPV

  

59.676

 < 0.001*

  

 Medium Risk

0.895

0.724

1.526

0.217

2.445

0.592–10.119

 High Risk

2.982

0.386

59.613

 < 0.001*

19.722

9.252–42.040

  1. *A p value of < 0.05 was considered to indicate significant difference